VENN STRATEGIES, LLC

Lobbying for UCB, INC. · Biopharmaceutical company dealing in severe diseases in immunology and neurology.

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2022 · Georgia · House · Senate · $40,000.00 income · posted Jul 2, 2026

Lobbying activity 2

Health Issues

Policies related to biopharmaceutical access and innovation.

Taxation/Internal Revenue Code

International tax policy proposals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.